WallStreetZenWallStreetZen

NASDAQ: MNOV
Medicinova Inc Stock Ownership - Who owns Medicinova?

Insider buying vs selling

Have Medicinova Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MNOV insiders and whales buy or sell their stock.

MNOV Shareholders

What type of owners hold Medicinova Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Jeff Himawan23.86%11,703,704$15.33MInsider
Essex Woodlands Health Ventures Fund Vi L P23.86%11,703,704$15.33MInsider
3d Investment Partners Pte Ltd11.22%5,502,047$7.21MInsider
Tanabe Holding America Inc10.19%5,000,000$6.55MInsider
Yuichi Iwaki8.34%4,091,933$5.36MInsider
Hajime Satomi2.99%1,467,000$1.92MInsider
Essex Woodlands Management Inc2.25%1,105,941$1.45MInstitution
Masatsune Okajima2.12%1,040,530$1.36MInsider
Kissei Pharmaceutical Co Ltd1.63%800,000$1.05MInsider
Kousuke Nakata1.63%800,000$1.05MInsider

1 of 3

MNOV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MNOV9.85%89.10%
RLYB43.27%56.73%
TSBX46.24%53.76%Net Buying
DTIL53.55%46.45%Net Selling
IKNA66.60%18.22%

Medicinova Stock Ownership FAQ

Who owns Medicinova?

Medicinova (NASDAQ: MNOV) is owned by 9.85% institutional shareholders, 89.10% Medicinova insiders, and 1.05% retail investors. Jeff Himawan is the largest individual Medicinova shareholder, owning 11.70M shares representing 23.86% of the company. Jeff Himawan's Medicinova shares are currently valued at $15.33M.

If you're new to stock investing, here's how to buy Medicinova stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.